Skip to main content
NCBI home page
American Journal of Human Genetics logoLink to American Journal of Human Genetics
. 1998 May;62(5):1034–1043. doi: 10.1086/301828

Mutations in btk in patients with presumed X-linked agammaglobulinemia.

M E Conley 1, D Mathias 1, J Treadaway 1, Y Minegishi 1, J Rohrer 1
PMCID: PMC1377085  PMID: 9545398

Abstract

In 1993, two groups showed that X-linked agammaglobulinemia (XLA) was due to mutations in a tyrosine kinase now called Btk. Most laboratories have been able to detect mutations in Btk in 80%-90% of males with presumed XLA. The remaining patients may have mutations in Btk that are difficult to identify, or they may have defects that are phenotypically similar to XLA but genotypically different. We analyzed 101 families in which affected males were diagnosed as having XLA. Mutations in Btk were identified in 38 of 40 families with more than one affected family member and in 56 of 61 families with sporadic disease. Excluding the patients in whom the marked decrease in B cell numbers characteristic of XLA could not be confirmed by immunofluorescence studies, mutations in Btk were identified in 43 of 46 patients with presumed sporadic XLA. Two of the three remaining patients had defects in other genes required for normal B cell development, and the third patient was unlikely to have XLA, on the basis of results of extensive Btk analysis. Our techniques were unable to identify a mutation in Btk in one male with both a family history and laboratory findings suggestive of XLA. DNA samples from 41 of 49 of the mothers of males with sporadic disease and proven mutations in Btk were positive for the mutation found in their son. In the other 8 families, the mutation appeared to arise in the maternal germ line. In 20 families, haplotype analysis showed that the new mutation originated in the maternal grandfather or great-grandfather. These studies indicate that 90%-95% of males with presumed XLA have mutations in Btk. The other patients are likely to have defects in other genes.

Full Text

The Full Text of this article is available as a PDF (1.4 MB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Allen R. C., Belmont J. W. Dinucleotide repeat polymorphism at the DXS178 locus. Hum Mol Genet. 1992 Jun;1(3):216–216. doi: 10.1093/hmg/1.3.216. [DOI] [PubMed] [Google Scholar]
  2. Allen R. C., Nachtman R. G., Rosenblatt H. M., Belmont J. W. Application of carrier testing to genetic counseling for X-linked agammaglobulinemia. Am J Hum Genet. 1994 Jan;54(1):25–35. [PMC free article] [PubMed] [Google Scholar]
  3. Becker J., Schwaab R., Möller-Taube A., Schwaab U., Schmidt W., Brackmann H. H., Grimm T., Olek K., Oldenburg J. Characterization of the factor VIII defect in 147 patients with sporadic hemophilia A: family studies indicate a mutation type-dependent sex ratio of mutation frequencies. Am J Hum Genet. 1996 Apr;58(4):657–670. [PMC free article] [PubMed] [Google Scholar]
  4. Bradley L. A., Sweatman A. K., Lovering R. C., Jones A. M., Morgan G., Levinsky R. J., Kinnon C. Mutation detection in the X-linked agammaglobulinemia gene, BTK, using single strand conformation polymorphism analysis. Hum Mol Genet. 1994 Jan;3(1):79–83. doi: 10.1093/hmg/3.1.79. [DOI] [PubMed] [Google Scholar]
  5. Carlson K. M., Bracamontes J., Jackson C. E., Clark R., Lacroix A., Wells S. A., Jr, Goodfellow P. J. Parent-of-origin effects in multiple endocrine neoplasia type 2B. Am J Hum Genet. 1994 Dec;55(6):1076–1082. [PMC free article] [PubMed] [Google Scholar]
  6. Conley M. E. B cells in patients with X-linked agammaglobulinemia. J Immunol. 1985 May;134(5):3070–3074. [PubMed] [Google Scholar]
  7. Conley M. E., Brown P., Pickard A. R., Buckley R. H., Miller D. S., Raskind W. H., Singer J. W., Fialkow P. J. Expression of the gene defect in X-linked agammaglobulinemia. N Engl J Med. 1986 Aug 28;315(9):564–567. doi: 10.1056/NEJM198608283150907. [DOI] [PubMed] [Google Scholar]
  8. Conley M. E., Fitch-Hilgenberg M. E., Cleveland J. L., Parolini O., Rohrer J. Screening of genomic DNA to identify mutations in the gene for Bruton's tyrosine kinase. Hum Mol Genet. 1994 Oct;3(10):1751–1756. doi: 10.1093/hmg/3.10.1751. [DOI] [PubMed] [Google Scholar]
  9. Conley M. E., Parolini O., Rohrer J., Campana D. X-linked agammaglobulinemia: new approaches to old questions based on the identification of the defective gene. Immunol Rev. 1994 Apr;138:5–21. doi: 10.1111/j.1600-065x.1994.tb00844.x. [DOI] [PubMed] [Google Scholar]
  10. Conley M. E., Puck J. M. Carrier detection in typical and atypical X-linked agammaglobulinemia. J Pediatr. 1988 May;112(5):688–694. doi: 10.1016/s0022-3476(88)80683-8. [DOI] [PubMed] [Google Scholar]
  11. Conley M. E., Rohrer J. The spectrum of mutations in Btk that cause X-linked agammaglobulinemia. Clin Immunol Immunopathol. 1995 Sep;76(3 Pt 2):S192–S197. doi: 10.1016/s0090-1229(95)90198-1. [DOI] [PubMed] [Google Scholar]
  12. Conley M. E., Sweinberg S. K. Females with a disorder phenotypically identical to X-linked agammaglobulinemia. J Clin Immunol. 1992 Mar;12(2):139–143. doi: 10.1007/BF00918144. [DOI] [PubMed] [Google Scholar]
  13. Farrar J. E., Rohrer J., Conley M. E. Neutropenia in X-linked agammaglobulinemia. Clin Immunol Immunopathol. 1996 Dec;81(3):271–276. doi: 10.1006/clin.1996.0188. [DOI] [PubMed] [Google Scholar]
  14. Fearon E. R., Winkelstein J. A., Civin C. I., Pardoll D. M., Vogelstein B. Carrier detection in X-linked agammaglobulinemia by analysis of X-chromosome inactivation. N Engl J Med. 1987 Feb 19;316(8):427–431. doi: 10.1056/NEJM198702193160802. [DOI] [PubMed] [Google Scholar]
  15. Goldberg Y. P., Kremer B., Andrew S. E., Theilmann J., Graham R. K., Squitieri F., Telenius H., Adam S., Sajoo A., Starr E. Molecular analysis of new mutations for Huntington's disease: intermediate alleles and sex of origin effects. Nat Genet. 1993 Oct;5(2):174–179. doi: 10.1038/ng1093-174. [DOI] [PubMed] [Google Scholar]
  16. Hagemann T. L., Chen Y., Rosen F. S., Kwan S. P. Genomic organization of the Btk gene and exon scanning for mutations in patients with X-linked agammaglobulinemia. Hum Mol Genet. 1994 Oct;3(10):1743–1749. doi: 10.1093/hmg/3.10.1743. [DOI] [PubMed] [Google Scholar]
  17. Hashimoto S., Tsukada S., Matsushita M., Miyawaki T., Niida Y., Yachie A., Kobayashi S., Iwata T., Hayakawa H., Matsuoka H. Identification of Bruton's tyrosine kinase (Btk) gene mutations and characterization of the derived proteins in 35 X-linked agammaglobulinemia families: a nationwide study of Btk deficiency in Japan. Blood. 1996 Jul 15;88(2):561–573. [PubMed] [Google Scholar]
  18. Hoffman T., Winchester R., Schulkind M., Frias J. L., Ayoub E. M., Good R. A. Hypoimmunoglobulinemia with normal T cell function in female siblings. Clin Immunol Immunopathol. 1977 May;7(3):364–371. doi: 10.1016/0090-1229(77)90070-8. [DOI] [PubMed] [Google Scholar]
  19. Jin H., Webster A. D., Vihinen M., Sideras P., Vorechovsky I., Hammarstróm L., Bernatowska-Matuszkiewicz E., Smith C. I., Bobrow M., Vetrie D. Identification of Btk mutations in 20 unrelated patients with X-linked agammaglobulinaemia (XLA). Hum Mol Genet. 1995 Apr;4(4):693–700. doi: 10.1093/hmg/4.4.693. [DOI] [PubMed] [Google Scholar]
  20. Kerner J. D., Appleby M. W., Mohr R. N., Chien S., Rawlings D. J., Maliszewski C. R., Witte O. N., Perlmutter R. M. Impaired expansion of mouse B cell progenitors lacking Btk. Immunity. 1995 Sep;3(3):301–312. doi: 10.1016/1074-7613(95)90115-9. [DOI] [PubMed] [Google Scholar]
  21. Ketterling R. P., Bottema C. D., Phillips J. A., 3rd, Sommer S. S. Evidence that descendants of three founders constitute about 25% of hemophilia B in the United States. Genomics. 1991 Aug;10(4):1093–1096. doi: 10.1016/0888-7543(91)90207-u. [DOI] [PubMed] [Google Scholar]
  22. Khan W. N., Alt F. W., Gerstein R. M., Malynn B. A., Larsson I., Rathbun G., Davidson L., Müller S., Kantor A. B., Herzenberg L. A. Defective B cell development and function in Btk-deficient mice. Immunity. 1995 Sep;3(3):283–299. doi: 10.1016/1074-7613(95)90114-0. [DOI] [PubMed] [Google Scholar]
  23. Knobloch O., Zoll B., Zerres K., Brackmann H. H., Olek K., Ludwig M. Recurrent mutations in the factor IX gene: founder effect or repeat de novo events. Investigation of the German haemophilia B population and review of de novo mutations. Hum Genet. 1993 Aug;92(1):40–48. doi: 10.1007/BF00216143. [DOI] [PubMed] [Google Scholar]
  24. Kornfeld S. J., Haire R. N., Strong S. J., Tang H., Sung S. S., Fu S. M., Litman G. W. A novel mutation (Cys145-->Stop) in Bruton's tyrosine kinase is associated with newly diagnosed X-linked agammaglobulinemia in a 51-year-old male. Mol Med. 1996 Sep;2(5):619–623. [PMC free article] [PubMed] [Google Scholar]
  25. Lederman H. M., Winkelstein J. A. X-linked agammaglobulinemia: an analysis of 96 patients. Medicine (Baltimore) 1985 May;64(3):145–156. [PubMed] [Google Scholar]
  26. Lupski J. R., de Oca-Luna R. M., Slaugenhaupt S., Pentao L., Guzzetta V., Trask B. J., Saucedo-Cardenas O., Barker D. F., Killian J. M., Garcia C. A. DNA duplication associated with Charcot-Marie-Tooth disease type 1A. Cell. 1991 Jul 26;66(2):219–232. doi: 10.1016/0092-8674(91)90613-4. [DOI] [PubMed] [Google Scholar]
  27. Lázaro C., Gaona A., Ainsworth P., Tenconi R., Vidaud D., Kruyer H., Ars E., Volpini V., Estivill X. Sex differences in mutational rate and mutational mechanism in the NF1 gene in neurofibromatosis type 1 patients. Hum Genet. 1996 Dec;98(6):696–699. doi: 10.1007/s004390050287. [DOI] [PubMed] [Google Scholar]
  28. McKinney R. E., Jr, Katz S. L., Wilfert C. M. Chronic enteroviral meningoencephalitis in agammaglobulinemic patients. Rev Infect Dis. 1987 Mar-Apr;9(2):334–356. doi: 10.1093/clinids/9.2.334. [DOI] [PubMed] [Google Scholar]
  29. Minegishi Y., Coustan-Smith E., Wang Y. H., Cooper M. D., Campana D., Conley M. E. Mutations in the human lambda5/14.1 gene result in B cell deficiency and agammaglobulinemia. J Exp Med. 1998 Jan 5;187(1):71–77. doi: 10.1084/jem.187.1.71. [DOI] [PMC free article] [PubMed] [Google Scholar]
  30. Ochs H. D., Smith C. I. X-linked agammaglobulinemia. A clinical and molecular analysis. Medicine (Baltimore) 1996 Nov;75(6):287–299. doi: 10.1097/00005792-199611000-00001. [DOI] [PubMed] [Google Scholar]
  31. Ohta Y., Haire R. N., Litman R. T., Fu S. M., Nelson R. P., Kratz J., Kornfeld S. J., de la Morena M., Good R. A., Litman G. W. Genomic organization and structure of Bruton agammaglobulinemia tyrosine kinase: localization of mutations associated with varied clinical presentations and course in X chromosome-linked agammaglobulinemia. Proc Natl Acad Sci U S A. 1994 Sep 13;91(19):9062–9066. doi: 10.1073/pnas.91.19.9062. [DOI] [PMC free article] [PubMed] [Google Scholar]
  32. Palau F., Löfgren A., De Jonghe P., Bort S., Nelis E., Sevilla T., Martin J. J., Vilchez J., Prieto F., Van Broeckhoven C. Origin of the de novo duplication in Charcot-Marie-Tooth disease type 1A: unequal nonsister chromatid exchange during spermatogenesis. Hum Mol Genet. 1993 Dec;2(12):2031–2035. doi: 10.1093/hmg/2.12.2031. [DOI] [PubMed] [Google Scholar]
  33. Parolini O., Hejtmancik J. F., Allen R. C., Belmont J. W., Lassiter G. L., Henry M. J., Barker D. F., Conley M. E. Linkage analysis and physical mapping near the gene for X-linked agammaglobulinemia at Xq22. Genomics. 1993 Feb;15(2):342–349. doi: 10.1006/geno.1993.1066. [DOI] [PubMed] [Google Scholar]
  34. Puck J. M., Pepper A. E., Bédard P. M., Laframboise R. Female germ line mosaicism as the origin of a unique IL-2 receptor gamma-chain mutation causing X-linked severe combined immunodeficiency. J Clin Invest. 1995 Feb;95(2):895–899. doi: 10.1172/JCI117740. [DOI] [PMC free article] [PubMed] [Google Scholar]
  35. Puck J. M., Pepper A. E., Henthorn P. S., Candotti F., Isakov J., Whitwam T., Conley M. E., Fischer R. E., Rosenblatt H. M., Small T. N. Mutation analysis of IL2RG in human X-linked severe combined immunodeficiency. Blood. 1997 Mar 15;89(6):1968–1977. [PubMed] [Google Scholar]
  36. Rawlings D. J., Witte O. N. Bruton's tyrosine kinase is a key regulator in B-cell development. Immunol Rev. 1994 Apr;138:105–119. doi: 10.1111/j.1600-065x.1994.tb00849.x. [DOI] [PubMed] [Google Scholar]
  37. Rohrer J., Conley M. E. Transcriptional regulatory elements within the first intron of Bruton's tyrosine kinase. Blood. 1998 Jan 1;91(1):214–221. [PubMed] [Google Scholar]
  38. Rohrer J., Parolini O., Belmont J. W., Conley M. E., Parolino O [corrected to Parolini O. ]. The genomic structure of human BTK, the defective gene in X-linked agammaglobulinemia. Immunogenetics. 1994;40(5):319–324. doi: 10.1007/BF01246672. [DOI] [PubMed] [Google Scholar]
  39. Rossiter J. P., Young M., Kimberland M. L., Hutter P., Ketterling R. P., Gitschier J., Horst J., Morris M. A., Schaid D. J., de Moerloose P. Factor VIII gene inversions causing severe hemophilia A originate almost exclusively in male germ cells. Hum Mol Genet. 1994 Jul;3(7):1035–1039. doi: 10.1093/hmg/3.7.1035. [DOI] [PubMed] [Google Scholar]
  40. Sideras P., Müller S., Shiels H., Jin H., Khan W. N., Nilsson L., Parkinson E., Thomas J. D., Brandén L., Larsson I. Genomic organization of mouse and human Bruton's agammaglobulinemia tyrosine kinase (Btk) loci. J Immunol. 1994 Dec 15;153(12):5607–5617. [PubMed] [Google Scholar]
  41. Smith C. I., Islam K. B., Vorechovský I., Olerup O., Wallin E., Rabbani H., Baskin B., Hammarström L. X-linked agammaglobulinemia and other immunoglobulin deficiencies. Immunol Rev. 1994 Apr;138:159–183. doi: 10.1111/j.1600-065x.1994.tb00851.x. [DOI] [PubMed] [Google Scholar]
  42. Stephens K., Kayes L., Riccardi V. M., Rising M., Sybert V. P., Pagon R. A. Preferential mutation of the neurofibromatosis type 1 gene in paternally derived chromosomes. Hum Genet. 1992 Jan;88(3):279–282. doi: 10.1007/BF00197259. [DOI] [PubMed] [Google Scholar]
  43. Tsukada S., Saffran D. C., Rawlings D. J., Parolini O., Allen R. C., Klisak I., Sparkes R. S., Kubagawa H., Mohandas T., Quan S. Deficient expression of a B cell cytoplasmic tyrosine kinase in human X-linked agammaglobulinemia. Cell. 1993 Jan 29;72(2):279–290. doi: 10.1016/0092-8674(93)90667-f. [DOI] [PubMed] [Google Scholar]
  44. Tuchman M., Matsuda I., Munnich A., Malcolm S., Strautnieks S., Briede T. Proportions of spontaneous mutations in males and females with ornithine transcarbamylase deficiency. Am J Med Genet. 1995 Jan 2;55(1):67–70. doi: 10.1002/ajmg.1320550118. [DOI] [PubMed] [Google Scholar]
  45. Vetrie D., Vorechovský I., Sideras P., Holland J., Davies A., Flinter F., Hammarström L., Kinnon C., Levinsky R., Bobrow M. The gene involved in X-linked agammaglobulinaemia is a member of the src family of protein-tyrosine kinases. Nature. 1993 Jan 21;361(6409):226–233. doi: 10.1038/361226a0. [DOI] [PubMed] [Google Scholar]
  46. Vihinen M., Iwata T., Kinnon C., Kwan S. P., Ochs H. D., Vorechovský I., Smith C. I. BTKbase, mutation database for X-linked agammaglobulinemia (XLA). Nucleic Acids Res. 1996 Jan 1;24(1):160–165. doi: 10.1093/nar/24.1.160. [DOI] [PMC free article] [PubMed] [Google Scholar]
  47. Vorechovsky I., Zhou J. N., Vetrie D., Bentley D., Björkander J., Hammarström L., Smith C. I., Vorechkovsky I. Molecular diagnosis of X-linked agammaglobulinaemia. Lancet. 1993 May 1;341(8853):1153–1153. doi: 10.1016/0140-6736(93)93172-w. [DOI] [PubMed] [Google Scholar]
  48. Vorechovský I., Luo L., Hertz J. M., Frøland S. S., Klemola T., Fiorini M., Quinti I., Paganelli R., Ozsahin H., Hammarström L. Mutation pattern in the Bruton's tyrosine kinase gene in 26 unrelated patients with X-linked agammaglobulinemia. Hum Mutat. 1997;9(5):418–425. doi: 10.1002/(SICI)1098-1004(1997)9:5<418::AID-HUMU7>3.0.CO;2-#. [DOI] [PubMed] [Google Scholar]
  49. Wicker L. S., Scher I. X-linked immune deficiency (xid) of CBA/N mice. Curr Top Microbiol Immunol. 1986;124:87–101. doi: 10.1007/978-3-642-70986-9_6. [DOI] [PubMed] [Google Scholar]
  50. Yel L., Minegishi Y., Coustan-Smith E., Buckley R. H., Trübel H., Pachman L. M., Kitchingman G. R., Campana D., Rohrer J., Conley M. E. Mutations in the mu heavy-chain gene in patients with agammaglobulinemia. N Engl J Med. 1996 Nov 14;335(20):1486–1493. doi: 10.1056/NEJM199611143352003. [DOI] [PubMed] [Google Scholar]
  51. Zhu Q., Zhang M., Winkelstein J., Chen S. H., Ochs H. D. Unique mutations of Bruton's tyrosine kinase in fourteen unrelated X-linked agammaglobulinemia families. Hum Mol Genet. 1994 Oct;3(10):1899–1900. doi: 10.1093/hmg/3.10.1899. [DOI] [PubMed] [Google Scholar]
  52. de Weers M., Mensink R. G., Kraakman M. E., Schuurman R. K., Hendriks R. W. Mutation analysis of the Bruton's tyrosine kinase gene in X-linked agammaglobulinemia: identification of a mutation which affects the same codon as is altered in immunodeficient xid mice. Hum Mol Genet. 1994 Jan;3(1):161–166. doi: 10.1093/hmg/3.1.161. [DOI] [PubMed] [Google Scholar]
  53. van Essen A. J., Abbs S., Baiget M., Bakker E., Boileau C., van Broeckhoven C., Bushby K., Clarke A., Claustres M., Covone A. E. Parental origin and germline mosaicism of deletions and duplications of the dystrophin gene: a European study. Hum Genet. 1992 Jan;88(3):249–257. doi: 10.1007/BF00197255. [DOI] [PubMed] [Google Scholar]

Articles from American Journal of Human Genetics are provided here courtesy of American Society of Human Genetics

RESOURCES